Antidiabetics in chronic kidney disease: new questions to new and traditional drugs
Antidiabéticos en insuficiencia renal crónica: nuevas preguntas a nuevos y clásicos fármacos
Read
6784
Timeswas read the article
2141
Total PDF
4643
Total HTML
Share statistics
array:21 [ "pii" => "X2013251412002205" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2012.Aug.11678" "estado" => "S300" "fechaPublicacion" => "2012-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:835" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3377 "formatos" => array:3 [ "EPUB" => 273 "HTML" => 2589 "PDF" => 515 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699512002208" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2012.Aug.11678" "estado" => "S300" "fechaPublicacion" => "2012-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2012;32:835" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5989 "formatos" => array:3 [ "EPUB" => 315 "HTML" => 5065 "PDF" => 609 ] ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "Antidiabéticos en insuficiencia renal crónica: nuevas preguntas a nuevos y clásicos fármacos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "835" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Antidiabetics in chronic kidney disease: new questions to new and traditional drugs" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Josep Serra-Tarragón" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Josep" "apellidos" => "Serra-Tarragón" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251412002205" "doi" => "10.3265/Nefrologia.pre2012.Aug.11678" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002205?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512002208?idApp=UINPBA000064" "url" => "/02116995/0000003200000006/v0_201502091338/X0211699512002208/v0_201502091339/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251412002182" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2012.Sep.11656" "estado" => "S300" "fechaPublicacion" => "2012-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:837-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3292 "formatos" => array:3 [ "EPUB" => 271 "HTML" => 2503 "PDF" => 518 ] ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Discrepancies between the summary of characteristics and the recommended use of metformin in the treatment of type 2 diabetes mellitus patients" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "837" "paginaFinal" => "838" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Discrepancias entre ficha técnica y recomendaciones de uso de metformina en el tratamiento de pacientes con diabetes mellitus tipo 2" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carlos del Pozo-Fernández, Carlos Pardo-Ruiz, Concepción Sánchez-Botella, Ramón López-Menchero" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Carlos" "apellidos" => "del Pozo-Fernández" ] 1 => array:2 [ "nombre" => "Carlos" "apellidos" => "Pardo-Ruiz" ] 2 => array:2 [ "nombre" => "Concepción" "apellidos" => "Sánchez-Botella" ] 3 => array:2 [ "nombre" => "Ramón" "apellidos" => "López-Menchero" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699512002185" "doi" => "10.3265/Nefrologia.pre2012.Sep.11656" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512002185?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002182?idApp=UINPBA000064" "url" => "/20132514/0000003200000006/v0_201502091602/X2013251412002182/v0_201502091603/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251412002190" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2012.Oct.11731" "estado" => "S300" "fechaPublicacion" => "2012-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:835-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4158 "formatos" => array:3 [ "EPUB" => 288 "HTML" => 3332 "PDF" => 538 ] ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "835" "paginaFinal" => "837" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "A propósito de las discrepancias entre documentos de consenso, guías de práctica clínica y normativa legal en el tratamiento de la diabetes tipo 2" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Alberto Martínez-Castelao, José L. Górriz, Eva Sola, Carlos Morillas, Ana Jover, Francisco Coronel, Juan Navarro-González, Fernando de Álvaro" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Alberto" "apellidos" => "Martínez-Castelao" ] 1 => array:2 [ "nombre" => "José L." "apellidos" => "Górriz" ] 2 => array:2 [ "nombre" => "Eva" "apellidos" => "Sola" ] 3 => array:2 [ "nombre" => "Carlos" "apellidos" => "Morillas" ] 4 => array:2 [ "nombre" => "Ana" "apellidos" => "Jover" ] 5 => array:2 [ "nombre" => "Francisco" "apellidos" => "Coronel" ] 6 => array:2 [ "nombre" => "Juan" "apellidos" => "Navarro-González" ] 7 => array:2 [ "nombre" => "Fernando" "apellidos" => "de Álvaro" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699512002193" "doi" => "10.3265/Nefrologia.pre2012.Oct.11731" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512002193?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002190?idApp=UINPBA000064" "url" => "/20132514/0000003200000006/v0_201502091602/X2013251412002190/v0_201502091603/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Antidiabetics in chronic kidney disease: new questions to new and traditional drugs" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "835" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Josep Serra-Tarragón" "autores" => array:1 [ 0 => array:4 [ "nombre" => "Josep" "apellidos" => "Serra-Tarragón" "email" => array:1 [ 0 => "jserra@xarxatecla.cat" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => "Medicina Familiar y Comunitaria. Àrea Bàsica Vila-seca. Xarxa Sanitària i Social de Santa Tecla, Vila-seca, Tarragona, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Antidiabéticos en insuficiencia renal crónica: nuevas preguntas a nuevos y clásicos fármacos" ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold"> </span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">To the Editor:</span></p><p class="elsevierStylePara">After reading the editorial by Martinez-Castelao A et al.,<span class="elsevierStyleSup">1</span> I must congratulate the authors for the clarity and pragmatism of their article.</p><p class="elsevierStylePara">The topic of chronic kidney disease (CKD), diabetes mellitus, and hypoglycaemic drugs continues to be a source of controversy among nephrologists and doctors from all areas who come into contact with and must make decisions regarding patients with renal failure who require these drugs.</p><p class="elsevierStylePara">Although the aforementioned editorial removes many of the doubts that may arise for primary care physicians who read the original article,<span class="elsevierStyleSup">2</span> it still leaves certain aspects somewhat unclear that we wish to highlight.</p><p class="elsevierStylePara">Why do classification systems for CKD continue to be in use when evaluating drugs that are not those proposed by the KDIGO several years ago?</p><p class="elsevierStylePara">The editorial includes the indications for new and traditional anti-diabetic drugs (Tables 2 and 3) based on the level of altered renal function in the patient, with glomerular filtration rates (GFR) >50ml/min, 30-50ml/min, or <30ml/min, referred to as mild, moderate, or severe, respectively. This classification system that differs from the more commonly used 5 stages established by the KDIGO (soon to undergo review) appear not only in this article, but also in the technical data sheets of several drugs, thus hindering the comparison between studies or protocols in the management of these drugs.</p><p class="elsevierStylePara">Due to what pathophysiological mechanisms, which are not sufficiently explained, is acarbose contraindicated in stage 4 and 5 patients, given that its mechanism of elimination is <2% renal?</p><p class="elsevierStylePara">A relatively large body of literature is available regarding the use of metformin, but very little is known regarding the adverse effects of acarbose.</p><p class="elsevierStylePara">New dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists are good resources to use when other drugs are contraindicated, but at times doubts can arise when treating patients with CKD, especially considering the fact that reduced doses for use in patients with CKD are often not available in Spain.</p><p class="elsevierStylePara">Has a pharmaco-toxic mechanism been isolated based upon which doses should be adjusted in the event of deteriorated capacity for renal elimination?</p><p class="elsevierStylePara"><br></br>Should we guide ourselves based on dosage or administration interval based on which drug is being administered?</p><p class="elsevierStylePara"><br></br>Although we are approaching a more updated and realistic version of the modern CKD patient with the imminent release of the S.E.N.-semFYC consensus document (and the debate continues whether a decrease in GFR<60 constitutes CKD, as held by the “huge” equation authors<span class="elsevierStyleSup">3</span>), and while the precision of estimates of GFR with cystatin-C alone or combined with serum creatinine is increasing,<span class="elsevierStyleSup">4</span> there are still doubts surrounding aspects of the treatment of this disease that have been around for some time.</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">Conflicts of interest</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">The author states that he has no potential conflicts of interest related to the contents of this article.</p><p class="elsevierStylePara"> </p>" "pdfFichero" => "P1-E544-S3784-A11678-EN.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Martínez-Castelao A, \u{A0}Górriz JL, Sola E, Morillas C, Jover A, Coronel F, et al. A propósito de las discrepancias entre documentos de consenso, guías de práctica clínica y normativa legal en el tratamiento de la diabetes tipo 2\u{A0}. Nefrologia 2012;32(4):419-26." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "del Pozo-Fernández C, Pardo-Ruiz C, Sánchez-Botella C, Blanes-Castaner V, López Menchero R, Gisbert-Sellés C, et al. Discrepancias entre documentos de consenso, guías, práctica clínica y normativa legal en el tratamiento de los pacientes con diabetes mellitus tipo 2. Nefrologia 2012;32(3):367-73. <a href="http://www.ncbi.nlm.nih.gov/pubmed/22592422" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Álvarez-Gregori JA, Robles NR, Mena C, Ardanuy R, Jauregui R, Macas Nu-Nunez JF. The value of a formula including haematocrit, blood urea and gender (HUGE) as a screening test for chronic renal insufficiency. J Nutr Health Aging 2011;15(6):480-4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21623470" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and \u{A0}cystatine C. N Engl J Med 2012;367(1):20-9." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003200000006/v0_201502091602/X2013251412002205/v0_201502091603/en/main.assets" "Apartado" => array:4 [ "identificador" => "35439" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor - Comments on published articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003200000006/v0_201502091602/X2013251412002205/v0_201502091603/en/P1-E544-S3784-A11678-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002205?idApp=UINPBA000064" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 6 | 9 | 15 |
| 2024 October | 34 | 33 | 67 |
| 2024 September | 48 | 27 | 75 |
| 2024 August | 56 | 48 | 104 |
| 2024 July | 40 | 33 | 73 |
| 2024 June | 48 | 33 | 81 |
| 2024 May | 54 | 30 | 84 |
| 2024 April | 46 | 39 | 85 |
| 2024 March | 36 | 29 | 65 |
| 2024 February | 41 | 36 | 77 |
| 2024 January | 40 | 23 | 63 |
| 2023 December | 26 | 30 | 56 |
| 2023 November | 44 | 27 | 71 |
| 2023 October | 43 | 28 | 71 |
| 2023 September | 45 | 37 | 82 |
| 2023 August | 44 | 16 | 60 |
| 2023 July | 38 | 42 | 80 |
| 2023 June | 35 | 23 | 58 |
| 2023 May | 47 | 34 | 81 |
| 2023 April | 30 | 13 | 43 |
| 2023 March | 46 | 17 | 63 |
| 2023 February | 45 | 27 | 72 |
| 2023 January | 47 | 25 | 72 |
| 2022 December | 51 | 39 | 90 |
| 2022 November | 46 | 34 | 80 |
| 2022 October | 59 | 37 | 96 |
| 2022 September | 37 | 32 | 69 |
| 2022 August | 38 | 47 | 85 |
| 2022 July | 28 | 41 | 69 |
| 2022 June | 26 | 42 | 68 |
| 2022 May | 31 | 29 | 60 |
| 2022 April | 29 | 48 | 77 |
| 2022 March | 34 | 58 | 92 |
| 2022 February | 39 | 48 | 87 |
| 2022 January | 47 | 29 | 76 |
| 2021 December | 35 | 37 | 72 |
| 2021 November | 34 | 33 | 67 |
| 2021 October | 33 | 41 | 74 |
| 2021 September | 21 | 32 | 53 |
| 2021 August | 32 | 38 | 70 |
| 2021 July | 17 | 29 | 46 |
| 2021 June | 26 | 19 | 45 |
| 2021 May | 37 | 34 | 71 |
| 2021 April | 44 | 29 | 73 |
| 2021 March | 55 | 34 | 89 |
| 2021 February | 36 | 19 | 55 |
| 2021 January | 24 | 16 | 40 |
| 2020 December | 32 | 9 | 41 |
| 2020 November | 18 | 12 | 30 |
| 2020 October | 17 | 18 | 35 |
| 2020 September | 16 | 7 | 23 |
| 2020 August | 21 | 15 | 36 |
| 2020 July | 27 | 10 | 37 |
| 2020 June | 23 | 10 | 33 |
| 2020 May | 31 | 13 | 44 |
| 2020 April | 30 | 12 | 42 |
| 2020 March | 21 | 8 | 29 |
| 2020 February | 36 | 22 | 58 |
| 2020 January | 31 | 19 | 50 |
| 2019 December | 24 | 17 | 41 |
| 2019 November | 19 | 10 | 29 |
| 2019 October | 6 | 5 | 11 |
| 2019 September | 19 | 23 | 42 |
| 2019 August | 19 | 5 | 24 |
| 2019 July | 15 | 20 | 35 |
| 2019 June | 16 | 13 | 29 |
| 2019 May | 10 | 14 | 24 |
| 2019 April | 49 | 33 | 82 |
| 2019 March | 22 | 19 | 41 |
| 2019 February | 12 | 15 | 27 |
| 2019 January | 22 | 16 | 38 |
| 2018 December | 47 | 30 | 77 |
| 2018 November | 57 | 17 | 74 |
| 2018 October | 43 | 16 | 59 |
| 2018 September | 41 | 10 | 51 |
| 2018 August | 41 | 9 | 50 |
| 2018 July | 29 | 8 | 37 |
| 2018 June | 34 | 13 | 47 |
| 2018 May | 23 | 12 | 35 |
| 2018 April | 43 | 5 | 48 |
| 2018 March | 27 | 9 | 36 |
| 2018 February | 23 | 5 | 28 |
| 2018 January | 40 | 9 | 49 |
| 2017 December | 33 | 9 | 42 |
| 2017 November | 31 | 7 | 38 |
| 2017 October | 31 | 7 | 38 |
| 2017 September | 27 | 14 | 41 |
| 2017 August | 24 | 5 | 29 |
| 2017 July | 28 | 13 | 41 |
| 2017 June | 21 | 8 | 29 |
| 2017 May | 37 | 11 | 48 |
| 2017 April | 27 | 10 | 37 |
| 2017 March | 23 | 9 | 32 |
| 2017 February | 22 | 6 | 28 |
| 2017 January | 16 | 10 | 26 |
| 2016 December | 35 | 9 | 44 |
| 2016 November | 36 | 6 | 42 |
| 2016 October | 81 | 11 | 92 |
| 2016 September | 50 | 2 | 52 |
| 2016 August | 91 | 2 | 93 |
| 2016 July | 136 | 10 | 146 |
| 2016 June | 109 | 0 | 109 |
| 2016 May | 115 | 0 | 115 |
| 2016 April | 91 | 0 | 91 |
| 2016 March | 84 | 0 | 84 |
| 2016 February | 89 | 0 | 89 |
| 2016 January | 79 | 0 | 79 |
| 2015 December | 110 | 0 | 110 |
| 2015 November | 84 | 0 | 84 |
| 2015 October | 82 | 0 | 82 |
| 2015 September | 41 | 0 | 41 |
| 2015 August | 64 | 0 | 64 |
| 2015 July | 73 | 0 | 73 |
| 2015 June | 39 | 0 | 39 |
| 2015 May | 41 | 0 | 41 |
| 2015 April | 11 | 0 | 11 |
Show all
